INS and polycystic ovary syndrome: MI supplementation at the dose of 2–4 g has shown to be effective in ameliorating both metabolic and reproductive features in PCOS women, reducing insulin plasma levels and IR, and improving the oocyte quality and menstrual cycle [8, 18–21].